Answers are grounded in this paper and cite their sources.
Demonstrates Jiajian Xiefei Tang's efficacy in alleviating asthma inflammation via Licochalcone A, suggesting its therapeutic potential.
studies demonstrated that Lico-A effectively reduced asthma-related cellular damage by inhibiting the STAT3/IL-17 signaling pathway. JJXFT attenuates asthma symptoms by modulating the STAT3/IL-17 signaling axis through its active component Lico-A, suggesting that JJXFT may function as a potential therapeutic agent for asthma.
No takes yet. Share an insight, caveat, or question.
Lv et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: